ArticleBMC pulmonary medicine2026
Deep learning-based super-resolution ultrashort echo time MRI for pulmonary nodule detection and longitudinal assessment in emphysema.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeThis study aimed to evaluate the performance of deep learning-based super-resolution ultrashort echo time magnetic resonance imaging (SR-UTE MRI) for the detection of pulmonary nodules and the reliability of longitudinal nodule size assessment compared with conventional ultrashort echo time (UTE) in patients with emphysema. MATERIALS AND
methodsThis prospective study included 127 patients with emphysema and pulmonary nodules who underwent chest low-dose computed tomography (LDCT) and UTE MRI. SR-UTE images were reconstructed using a deep learning-based algorithm. Pulmonary nodule detection performance, size measurement accuracy, and longitudinal reproducibility were assessed using LDCT as the reference standard. Patients were stratified according to CT-derived emphysema severity quantified by low-attenuation area percentage (LAA%). Objective image quality metrics, including signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and Laplacian variance, were also evaluated.
resultsSR-UTE demonstrated superior image quality compared with conventional UTE, with higher SNR and CNR in patients with severe emphysema (both p < 0.05). For nodules < 6 mm, SR-UTE achieved a higher detection rate than UTE (81.8% vs. 54.5%, p < 0.05), with greater improvement for ground-glass nodules in severe emphysema (66.7% vs. 33.3%). Both UTE and SR-UTE achieved 100% sensitivity for nodules > 8 mm. SR-UTE showed better agreement with CT for nodule size measurement, with higher intraclass correlation coefficients across emphysema subgroups (0.89-0.93 vs. 0.84-0.88 for UTE) and reduced measurement bias. In longitudinal analysis, SR-UTE more accurately reflected CT-derived nodule size changes and demonstrated higher reproducibility than UTE (ICC 0.90 vs. 0.82).
conclusionSR-UTE improved the detection of small and subsolid pulmonary nodules and provided more reliable longitudinal size assessment than UTE in patients with emphysema. These findings support the potential role of SR-UTE MRI in MRI-based surveillance of pulmonary nodules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.